2015: Real-world data for benefit assessments: How can registries and routine data contribute?

Presentations

Friday, 27.November 2015

  •  Do we need real-world data for benefit assessments? (German version)
  •  The contribution of clinical cancer registries for benefit assessments: requirements and results so far (German version)
  •  Medical care for severely injured patients: TraumaRegister DGU (German version)
  •  Possibilities and pitfalls when using routine data for benefit assessments (German version)
  •  Is the age of causality over? (German version)

Saturday, 28.November 2015

  •  Adaptive Pathways to Patients: The expected contribution of "Real World Data" (presentation in German)
  •  How "Real World Data" compensate for scarce evidence in HTA
  •  Earlier drug approval – an opportunity for patients? (German version)
  •  Earlier drug approval – a risk for patients? (German version)

Further information: